Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, GENTAUR another in time delivery

Pubmed ID :29400603
Publication Date : //

A novel bicistronic gene design couples stable cell line selection with a fucose switch in a designer CHO host to produce native and afucosylated glycoform antibodies.


The conserved glycosylation site Asn of a monoclonal antibody (mAb) can be decorated with a variety of sugars that can alter mAb pharmacokinetics and recruitment of effector proteins. Antibodies lacking the core fucose at Asn (afucosylated mAbs) show enhanced antibody-dependent cell-mediated cytotoxicity (ADCC) and increased efficacy. Here, we describe the development of a robust platform for the manufacture of afucosylated therapeutic mAbs by engineering a Chinese hamster ovary (CHO) host cell line to co-express a mAb with GDP-6-deoxy-D-lyxo-4-hexulose reductase (RMD), a prokaryotic enzyme that deflects an intermediate in the de novo synthesis of fucose to a dead-end product, resulting in the production of afucosylated mAb (GlymaxX™ Technology, ProBioGen). Expression of the mAb and RMD genes was coordinated by co-transfection of separate mAb and RMD vectors or use of an internal ribosome entry site (IRES) element to link the translation of RMD with either the glutamine synthase selection marker or the mAb light chain. The GS-IRES-RMD vector format was more suitable for the rapid generation of high yielding cell lines, secreting afucosylated mAb with titers exceeding 6.0 g/L. These cell lines maintained production of afucosylated mAb over 60 generations, ensuring their suitability for use in large-scale manufacturing. The afucosylated mAbs purified from these RMD-engineered cell lines showed increased binding in a CD16 cellular assay, demonstrating enhancement of ADCC compared to fucosylated control mAb. Furthermore, the afucosylation in these mAbs could be controlled by simple addition of L-fucose in the culture medium, thereby allowing the use of a single cell line for production of the same mAb in fucosylated and afucosylated formats for multiple therapeutic indications.

Authors : Roy Gargi , Martin Tom , Barnes Arnita , Wang Jihong , Jimenez Rod Brian , Rice Megan , Li Lina , Feng Hui , Zhang Shu , Chaerkady Raghothama , Wu Herren , Marelli Marcello , Hatton Diane , Zhu Jie , Bowen Michael A ,

Related products :

Catalog number Product name Quantity
SL-0002 Stable cell line: Estrogen Receptor Luciferase Reporter T47D Stable Cell Line
SC012 TAT stable cells: Stable cell line expressing codon humanized TAT gene and RFP with Blasticidin resistance 2 x 106 cell/ml x 1ml
SL-0001 Stable cell line: NFkB Luciferase Reporter HeLa Stable Cell Line
SC018-Bsd Color Switch, CRE report cell line: HEK293-loxP-GFP-RFP (Bsd) : CRE reporter cell line (Bsd): HEK293 cell line expressing "LoxP-GFP-stop-LoxP-RFP" cassette with Blasticidin antibiotic marker 2x10E6 cell/ml x1ml
SC018-Neo Color Switch, CRE report cell line: HEK293-loxP-GFP-RFP Neo) : CRE reporter cell line (Neo): HEK293 cell line expressing "LoxP-GFP-stop-LoxP-RFP" cassette with Neomycin antibiotic marker 2x10E6 cell/ml x1ml
SL-0101 Stable cell line: NFkB (p65) Overexpression Stable Cell Line
SC017 h NANOG stable cells: Stable cell line expressing human NANOG gene and RFP with Blasticidin resistance 2 x 106 cell/ml x 1ml
SC015 h OCT3_4 stable cells: Stable cell line expressing human OCT3_4 gene and RFP with Blasticidin resistance 2 x 106 cell/ml x 1ml
SC016 h LIN28 stable cells: Stable cell line expressing human Lin28 gene and RFP with Blasticidin resistance 2 x 106 cell/ml x 1ml
SC014 Inducible h P53 stable cells: Inducible expression stable cell line for human P53 gene, containing RFP-Blasticidin fusion marker and Puromycin resistance. 2 x 106 cell/ml x 1ml
SL-0100 Stable cell line: p53 Overexpression Stable Cell Line
SC021-Puro Luciferase (firefly) and CRE co-expression stable cell line (puromycin), stable cell lines 2 x 106 cell/ml x 1ml
SC018-Puro Color Switch, CRE report cell line: HEK293-loxP-GFP-RFP (Puro) : CRE reporter cell line (Puro): HEK293 cell line expressing "LoxP-GFP-stop-LoxP-RFP" cassette with Puromycin antibiotic marker 2x10E6 cell/ml x1ml
SC021-RP Luciferase (firefly) and CRE co-expression stable cell line (RFP-puromycin), stable cell lines 2 x 106 cell/ml x 1ml
SC021-GB Luciferase (firefly) and CRE co-expression stable cell line (GFP-Blasticidin), stable cell lines 2 x 106 cell/ml x 1ml
SC030 inducible GFP HEK293 stable cell line with RFP marker, stable cell lines 2 x 106 cell/ml x 1ml
SC029 inducible RFP HEK293 stable cell line with GFP marker, stable cell lines 2 x 106 cell/ml x 1ml
SC013 Glutamine Synthesis stable cells: Stable cell line expressing Glutamine Synthesis gene and RFP with Blasticidin resistance 2 x 106 cell/ml x 1ml
SC028 Inducible RFP HEK293 stable cell line, stable cell lines 2 x 106 cell/ml x 1ml
SC009 GFP & RFP stable cells: Stable cell line expressing GFP and RFP with Blasticidin resistance 2 x 106 cell/ml x 1ml
SC006 Flp stable cells: Flp recombinase stable cell line with Blasticidin resistance 2 x 106 cell/ml x 1ml
SC007 293-RFP stable cells: Humanized Red fluorescent protein (RFP) stable cell line with Blasticidin resistance 2 x 106 cell/ml x 1ml
SC004-Bsd CRE stable cells with Puromycin marker: CRE recombinase stable cell line with Blasticidin resistance 2 x 106 cell/ml x 1ml
SC004-Neo CRE stable cells with Puromycin marker: CRE recombinase stable cell line with Neomycin resistance 2 x 106 cell/ml x 1ml
SC021-RP Luciferase (firefly) and CRE co-expression stable cell line (RFP-puromycin): Luciferase (firefly) and CRE recombinase co-expression stable cell line with RFP-Puromycin fusion dual marker. 2 x 106 cell/ml x 1ml


 

GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45

Fax 0032 16 50 90 45
info@gentaur.com | Gentaur





GENTAUR Ltd.
Howard Frank Turnberry House
1404-1410 High Road
Whetstone London N20 9BH
Tel 020 3393 8531 Fax 020 8445 9411
uk@gentaur.com | Gentaur

 

 




GENTAUR France SARL
9, rue Lagrange, 75005 Paris
Tel 01 43 25 01 50

Fax 01 43 25 01 60
RCS Paris B 484 237 888

SIRET 48423788800017

BNP PARIBAS PARIS PL MAUBERT BIC BNPAFRPPPRG

france@gentaur.com | Gentaur

GENTAUR GmbH
Marienbongard 20
52062 Aachen Deutschland
Support Karolina Elandt
Tel: 0035929830070
Fax: (+49) 241 56 00 47 88

Logistic :0241 40 08 90 86
Bankleitzahl 39050000
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
Steuernummer 201/5961/3925
de@gentaur.com | Gentaur

GENTAUR U.S.A
Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,
sales@genprice.com

Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123




GENTAUR Nederland BV
NL850396268B01 KVK nummer 52327027
Kuiper 1
5521 DG Eersel Nederland
Tel:  0208-080893  Fax: 0497-517897
nl@gentaur.com | Gentaur
IBAN: NL04 RABO 0156 9854 62   SWIFT RABONL2U






GENTAUR Spain
tel:0911876558
spain@gentaur.com | Gentaur






ГЕНТАУЪР БЪЛГАРИЯ
ID # 201 358 931 /BULSTAT
София 1000, ул. "Граф Игнатиев" 53 вх. В, ет. 2
Tel 0035924682280 Fax 0035924808322
e-mail: Sofia@gentaur.com | Gentaur
IBAN: BG11FINV91501014771636
BIC: FINVBGSF

GENTAUR Poland Sp. z o.o.


ul. Grunwaldzka 88/A m.2
81-771 Sopot, Poland
TEL Gdansk 058 710 33 44 FAX  058 710 33 48              

poland@gentaur.com | Gentaur

Other countries

Österreich +43720880899

Canada Montreal +15149077481

Ceská republika Praha +420246019719

Danmark +4569918806

Finland Helsset +358942419041

Magyarország Budapest +3619980547

Ireland Dublin+35316526556

Luxembourg+35220880274

Norge Oslo+4721031366

Sverige Stockholm+46852503438

Schweiz Züri+41435006251

US New York+17185132983

GENTAUR Italy
SRL IVA IT03841300167
Piazza Giacomo Matteotti, 6
24122 Bergamo Tel 02 36 00 65 93
Fax 02 36 00 65 94
italia@gentaur.com | Gentaur